🔎 Trials Near Me

Home › Ovarian Cancer › Georgia › Atlanta

Ovarian Cancer clinical trials in Atlanta, GA

29 studies for Ovarian Cancer are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

RecruitingPhase 2/3
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • Emory Saint Joseph's Hospital, Atlanta
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT07001748

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

RecruitingPhase 1
  • Winship Cancer Institute of Emory University, Atlanta
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06270706

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

RecruitingPhase 1
  • Emory University, Atlanta
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06465069

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

RecruitingPhase 1
  • Emory Winship Cancer Institute, Atlanta
Ages 19 and older · All sexes · Updated Oct 1, 2026 · NCT06586957

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

RecruitingObservational study
  • Piedmont Healthcare, Atlanta
Ages 18 and older · Women · Updated Sep 29, 2026 · NCT05051722

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

RecruitingPhase 2
  • Site 0108 - Emory University Hospital, Atlanta
Ages 18 and older · Women · Updated Sep 29, 2026 · NCT05128825

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

RecruitingPhase 3
  • Winship Cancer Institute, Emory University, Atlanta
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07213804

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

RecruitingPhase 3
  • Winship Cancer Institute of Emory University ( Site 0037), Atlanta
Ages 18 and older · Women · Updated Sep 17, 2026 · NCT07318558

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

RecruitingPhase 3
  • Winship Cancer Institute At Emory University, Atlanta
Ages 18 and older · Women · Updated Sep 15, 2026 · NCT07214779

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

RecruitingPhase 1/2
  • Emory University, Atlanta
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT06303505

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

RecruitingPhase 1
  • Emory University, Atlanta
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT06400472

Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers

RecruitingPhase 2
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • Emory Saint Joseph's Hospital, Atlanta
Ages 18 and older · Women · Updated Aug 27, 2026 · NCT06492070

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

RecruitingPhase 1
  • Emory University - Winship Cancer Institute, Atlanta
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT06582017

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

RecruitingPhase 1
  • Winship Cancer Institute, Emory University, Atlanta
Ages 15 and older · All sexes · Updated Aug 25, 2026 · NCT06276491

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

RecruitingPhase 1/2
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
12 Months – 30 Years · All sexes · Updated Aug 25, 2026 · NCT04851119

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Recruiting
  • Grady Health System, Atlanta
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • and 3 more
Ages 35 to 50 · Women · Updated Aug 7, 2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

RecruitingPhase 3
  • Grady Health System, Atlanta
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • and 3 more
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT06580314

Clinical Pre-screening Protocol for Ovarian Cancer

RecruitingObservational study
  • Emory Winship Cancer Institute, Atlanta
Ages 18 and older · Women · Updated Jul 30, 2026 · NCT03877796

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

RecruitingPhase 1/2
  • Winship Cancer Institute, Emory University, Atlanta
Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT05768139

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

RecruitingPhase 1/2
  • Winship Cancer Institute, Emory University, Atlanta
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05377996

A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

RecruitingPhase 2
  • GSK Investigational Site, Atlanta
Ages 18 and older · All sexes · Updated Jun 24, 2026 · NCT04641247

Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics

RecruitingHealthy volunteers welcome
  • Emory University Hospital/Winship Cancer Institute, Atlanta
Ages 25 and older · Women · Updated May 26, 2026 · NCT06760507

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

RecruitingPhase 2
  • USA10-0, Atlanta
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT06953089

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

RecruitingPhase 1/2
  • Emory Winship Cancer Institute, Atlanta
Ages 18 and older · All sexes · Updated Apr 1, 2026 · NCT05735080

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

RecruitingPhase 2
  • Winship Cancer Institute, Emory University, Atlanta
Ages 18 and older · Women · Updated Dec 23, 2025 · NCT06690775

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Atlanta
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

A Beta-only IL-2 ImmunoTherapY Study

RecruitingPhase 1/2
  • Emory - Winship Cancer Institute, Atlanta
Ages 18 and older · All sexes · Updated Jul 9, 2025 · NCT05086692

About Ovarian Cancer

Ovarian cancer is a cancerous tumor that forms in the tissues of an ovary. The ovaries are a pair of female reproductive glands that make eggs and female hormones.

More about Ovarian Cancer on MedlinePlus

Ovarian Cancer trials in other cities

Other studies in Atlanta

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.